Clinical Translation of a Novel Albumin-Binding PET Radiotracer 68Ga-NEB
Status:
Unknown status
Trial end date:
2017-12-01
Target enrollment:
Participant gender:
Summary
This is an open-label whole-body PET/CT study for investigation of radiation dosimetry,
plasma pharmacokinetics, biodistribution, safety and diagnostic performance of 68Ga-NEB in
healthy volunteers and patients with suspected infection. Changes of routine blood and urine
tests and any adverse events will be collected from the volunteers. Adverse events will also
be observed in the patients.
Phase:
Phase 1
Details
Lead Sponsor:
Peking Union Medical College Hospital
Collaborator:
National Institute for Biomedical Imaging and Bioengineering (NIBIB)